Preaching to the converted

Debt and biotech have always had an oil and water feel, given that most companies don't have the cash flow to meet the interest payments. But that hasn't kept investors from throwing money at companies in exchange for IOUs over the years. Now the convert market has hotted up again, with $1.2 billion of debt pricing last week, bringing to $1.7 billion

Read the full 628 word article

How to gain access

Continue reading with a
two-week free trial.